Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
Bucciardini R, Fragola V, Abegaz T, Lucattini S, Halifom A, Tadesse E, Berhe M, Pugliese K, Binelli A, De Castro P, Terlizzi R, Fucili L, Di Gregorio M, Mirra M, Olivieri E, Teklu T, Zegeye T, Haile A, Vella S, Abraham L, Godefay H; CASA-project Health Facilities. Bucciardini R, et al. Among authors: vella s. PLoS One. 2015 Sep 4;10(9):e0136117. doi: 10.1371/journal.pone.0136117. eCollection 2015. PLoS One. 2015. PMID: 26340271 Free PMC article.
Predictors of attrition from care at 2 years in a prospective cohort of HIV-infected adults in Tigray, Ethiopia.
Bucciardini R, Fragola V, Abegaz T, Lucattini S, Halifom A, Tadesse E, Berhe M, Pugliese K, Fucili L, Gregorio MD, Mirra M, Castro P, Terlizzi R, Tatarelli P, Binelli A, Zegeye T, Campagnoli M, Vella S, Abraham L, Godefay H. Bucciardini R, et al. Among authors: vella s. BMJ Glob Health. 2017 Aug 6;2(3):e000325. doi: 10.1136/bmjgh-2017-000325. eCollection 2017. BMJ Glob Health. 2017. PMID: 29082011 Free PMC article.
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.
Palmisano L, Giuliano M, Bucciardini R, Fragola V, Andreotti M, Galluzzo C, Pirillo MF, Weimer LE, Arcieri R, Germinario EA, Amici R, Mancini MG, Monforte Ad, Castelli F, Caramello P, Vella S; Italian ISS-PART Clinical Centers. Palmisano L, et al. Among authors: vella s. J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):39-47. J Acquir Immune Defic Syndr. 2007. PMID: 17972364 Clinical Trial.
Validation of a self-reported HIV symptoms list: the ISS-HIV symptoms scale.
Bucciardini R, Pugliese K, Francisci D, Costantini A, Schiaroli E, Cognigni M, Tontini C, Lucattini S, Fucili L, Di Gregorio M, Mirra M, Fragola V, Pompili S, Murri R, Vella S. Bucciardini R, et al. Among authors: vella s. AIDS Res Ther. 2016 Apr 9;13:18. doi: 10.1186/s12981-016-0102-2. eCollection 2016. AIDS Res Ther. 2016. PMID: 27064450 Free PMC article.
Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir.
George EC, Bucciardini R, Richert L, Dedes N, Fragola V, Nieuwkerk P, Spire B, Volny-Anne A, West B, Molina JM, Horban A, Fox J, Pozniak A, Vella S, Termote M, Raffi F; NEAT 001/ANRS 143 Study Group. George EC, et al. Among authors: vella s. J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):519-526. doi: 10.1097/QAI.0000000000001844. J Acquir Immune Defic Syndr. 2018. PMID: 30234665 Free PMC article. Clinical Trial.
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
Pirillo M, Palmisano L, Pellegrini M, Galluzzo C, Weimer L, Bucciardini R, Fragola V, Andreotti M, Marchei E, Pichini S, Vella S, Giuliano M. Pirillo M, et al. Among authors: vella s. AIDS Res Hum Retroviruses. 2010 May;26(5):541-5. doi: 10.1089/aid.2009.0116. AIDS Res Hum Retroviruses. 2010. PMID: 20455761 Clinical Trial.
Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery.
Giuliano M, Andreotti M, Liotta G, Jere H, Sagno JB, Maulidi M, Mancinelli S, Buonomo E, Scarcella P, Pirillo MF, Amici R, Ceffa S, Vella S, Palombi L, Marazzi MC. Giuliano M, et al. Among authors: vella s. PLoS One. 2013 Jul 19;8(7):e68950. doi: 10.1371/journal.pone.0068950. Print 2013. PLoS One. 2013. PMID: 23894379 Free PMC article.
599 results